NDC properties for "testosterone 50 MG Transdermal Gel, 5 GM" (RxCUI 1597129)
About this data
The tables show NDC propoerties for testosterone 50 MG Transdermal Gel, 5 GM with the RxCUI 1597129
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone 50 MG Transdermal Gel, 5 GM (RxCUI 1597129)
| ANDA | ANDA076737 |
|---|---|
| ANDA | ANDA076744 |
| ANDA | ANDA091073 |
| ANDA | ANDA212984 |
| MMSL_CODE | BD22847 |
| MMSL_CODE | CD12427 |
| MMSL_CODE | CD22847 |
| RxCUI | 1597129 |
| SPL_SET_ID | 5834d34f-839d-412c-b74c-da1dad2cfa88 |
| SPL_SET_ID | 7b40a5ea-5d65-48d5-bafd-6f71b98ff6e7 |
| SPL_SET_ID | 7d655d6d-01da-488c-bd4e-c7fbe0ace38c |
| SPL_SET_ID | a887020f-b41f-49fe-8379-f01147b2a796 |
| SPL_SET_ID | e18b4495-c5a3-4a7f-9636-179320784381 |
| SPL_SET_ID | ee54c393-bcfe-4a52-b7b3-1da8750f35d9 |
| VUID | 4014744 |
| VUID | 4034718 |
| VUID | 4034719 |
| VUID | 4043148 |
| Prescribable Synonym | testosterone 1 % (50 MG / 5 GM) Transdermal Gel |
| RXNAV_STR | 5000 MG testosterone 0.01 MG/MG Topical Gel |
| RxNorm Name | 5000 MG testosterone 0.01 MG/MG Topical Gel |
| RxNorm Synonym | testosterone 50 MG Transdermal Gel, 5 GM |
| Related queries | Interactions (for RxCUI 1597129) |
NDC Properties
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 00591321726
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-26 |
| NDC Item | 00591321726 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591321730
| NDC 9 | 0591-3217 |
|---|---|
| NDC 10 | 0591-3217-30 |
| NDC Item | 00591321730 |
| Packaging | 30 PACKET in 1 CARTON (0591-3217-30) / 5 g in 1 PACKET (0591-3217-26) |
| ANDA | ANDA076737 |
| DCSA | CIII |
| FDA SPL set id | 701373 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-12-04 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3217 |
NDC Item 00591352426
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-26 |
| NDC Item | 00591352426 |
| Packaging | 5 g in 1 TUBE |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00591352430
| NDC 9 | 0591-3524 |
|---|---|
| NDC 10 | 0591-3524-30 |
| NDC Item | 00591352430 |
| Packaging | 30 TUBE in 1 CARTON (0591-3524-30) / 5 g in 1 TUBE (0591-3524-26) |
| ANDA | ANDA091073 |
| DCSA | CIII |
| FDA SPL set id | 738425 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2017-10-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-3524 |
NDC Item 00832112005
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-05 |
| NDC Item | 00832112005 |
| Packaging | 30 TUBE in 1 CARTON (0832-1120-05) / 5 g in 1 TUBE (0832-1120-65) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112035
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-35 |
| NDC Item | 00832112035 |
| Packaging | 30 PACKET in 1 CARTON (0832-1120-35) / 5 g in 1 PACKET (0832-1120-89) |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112065
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-65 |
| NDC Item | 00832112065 |
| Packaging | 5 g in 1 TUBE |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 00832112089
| NDC 9 | 0832-1120 |
|---|---|
| NDC 10 | 0832-1120-89 |
| NDC Item | 00832112089 |
| Packaging | 5 g in 1 PACKET |
| COLORTEXT | WHITE(clear, transluscent) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 710489 |
| Labeler | Upsher-Smith Laboratories, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2014-06-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA204399 |
| Related queries | Properties for NDC 9 0832-1120 |
NDC Item 21922001902
| NDC 9 | 21922-019 |
|---|---|
| NDC 10 | 21922-019-02 |
| NDC Item | 21922001902 |
| Packaging | 30 PACKET in 1 CARTON (21922-019-02) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 770936 |
| Labeler | Encube Ethicals Private Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-01-10 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 21922-019 |
NDC Item 49884051063
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-63 |
| NDC Item | 49884051063 |
| Packaging | 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 49884051072
| NDC 9 | 49884-510 |
|---|---|
| NDC 10 | 49884-510-72 |
| NDC Item | 49884051072 |
| Packaging | 30 PACKET in 1 CARTON (49884-510-72) / 5 g in 1 PACKET (49884-510-63) |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 660010 |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 49884-510 |
NDC Item 63629212501
| NDC 9 | 63629-2125 |
|---|---|
| NDC 10 | 63629-2125-1 |
| NDC Item | 63629212501 |
| Packaging | 30 PACKET in 1 CARTON (63629-2125-1) / 5 g in 1 PACKET |
| ANDA | ANDA076744 |
| DCSA | CIII |
| FDA SPL set id | 762728 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-09-02 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 63629-2125 |
NDC Item 63629958501
| NDC 9 | 63629-9585 |
|---|---|
| NDC 10 | 63629-9585-1 |
| NDC Item | 63629958501 |
| Packaging | 30 PACKET in 1 CARTON (63629-9585-1) / 5 g in 1 PACKET |
| ANDA | ANDA212984 |
| DCSA | CIII |
| FDA SPL set id | 785842 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2021-11-19 |
| Marketing status | COMPLETED |
| Related queries | Properties for NDC 9 63629-9585 |
NDC Item 64380015201
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-01 |
| NDC Item | 64380015201 |
| Packaging | 5 g in 1 DOSE PACK |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 64380015202
| NDC 9 | 64380-152 |
|---|---|
| NDC 10 | 64380-152-02 |
| NDC Item | 64380015202 |
| Packaging | 30 DOSE PACK in 1 CARTON (64380-152-02) / 5 g in 1 DOSE PACK (64380-152-01) |
| ANDA | ANDA076744 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| DCSA | CIII |
| FDA SPL set id | 793741 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 64380-152 |
NDC Item 66993093430
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-30 |
| NDC Item | 66993093430 |
| Packaging | 30 TUBE in 1 CARTON (66993-934-30) / 5 g in 1 TUBE (66993-934-54) |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |
NDC Item 66993093454
| NDC 9 | 66993-934 |
|---|---|
| NDC 10 | 66993-934-54 |
| NDC Item | 66993093454 |
| DCSA | CIII |
| FDA SPL set id | 304583 |
| Labeler | Prasco Laboratories |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2019-02-12 |
| Marketing effective time low | 2014-06-09 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021454 |
| Related queries | Properties for NDC 9 66993-934 |